In fact, TNF/TNFR system represents the single largest and validated therapeutic target in the clinics, accounting for major chronic autoimmune diseases, such as rheumatoid arthritis and psoriasis21. The gene discussed is TNFRSF1A; the disease is rheumatoid arthritis.